Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Amerisourcebergen stock price, quote, forecast and news

ABC
US03073E1055
766149

Price

185.41
Today +/-
+0
Today %
+0 %
P

Amerisourcebergen stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Amerisourcebergen stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Amerisourcebergen stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Amerisourcebergen stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Amerisourcebergen's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Amerisourcebergen Stock Price History

DateAmerisourcebergen Price
10/30/2023185.41 undefined
10/30/2023185.41 undefined

Amerisourcebergen Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Amerisourcebergen, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Amerisourcebergen from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Amerisourcebergen’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Amerisourcebergen. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Amerisourcebergen’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Amerisourcebergen’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Amerisourcebergen’s growth potential.

Amerisourcebergen Revenue, EBIT and net profit per share

DateAmerisourcebergen RevenueAmerisourcebergen EBITAmerisourcebergen Net Income
2028e349.93 B undefined4.46 B undefined3.65 B undefined
2027e333.35 B undefined4.22 B undefined3.39 B undefined
2026e318.56 B undefined3.97 B undefined3.1 B undefined
2025e289.4 B undefined3.79 B undefined2.85 B undefined
2024e275.03 B undefined3.54 B undefined2.6 B undefined
2023e260.75 B undefined3.31 B undefined2.41 B undefined
2022238.59 B undefined2.79 B undefined1.7 B undefined
2021213.99 B undefined2.68 B undefined1.54 B undefined
2020189.89 B undefined2.02 B undefined-3.41 B undefined
2019179.59 B undefined1.87 B undefined855 M undefined
2018167.94 B undefined1.72 B undefined1.66 B undefined
2017153.14 B undefined2.02 B undefined364 M undefined
2016146.85 B undefined1.54 B undefined1.43 B undefined
2015135.96 B undefined395 M undefined-138 M undefined
2014119.57 B undefined766 M undefined274 M undefined
201387.96 B undefined944 M undefined434 M undefined
201278.08 B undefined1.36 B undefined719 M undefined
201178.7 B undefined1.22 B undefined707 M undefined
201077.78 B undefined1.09 B undefined637 M undefined
200971.76 B undefined901 M undefined503 M undefined
200870.19 B undefined846 M undefined251 M undefined
200765.67 B undefined795 M undefined469 M undefined
200660.81 B undefined713 M undefined468 M undefined
200554.58 B undefined665 M undefined265 M undefined
200453.12 B undefined908 M undefined468 M undefined
200349.58 B undefined895 M undefined441 M undefined

Amerisourcebergen Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023e2024e2025e2026e2027e2028e
2.562.833.333.664.184.675.668.39.59.8111.6516.1945.2449.5853.1254.5860.8165.6770.1971.7677.7878.778.0887.96119.57135.96146.85153.14167.94179.59189.89213.99238.59260.75275.03289.4318.56333.35349.93
-10.2617.799.8814.2911.6521.2946.5514.513.2018.7439.04179.389.617.132.7411.427.996.882.248.381.18-0.7812.6535.9413.718.014.299.666.945.7412.6911.499.295.485.2310.084.644.97
6.326.336.015.715.625.705.334.874.864.824.474.324.474.494.083.633.493.382.922.932.993.133.392.882.472.552.822.972.772.782.733.173.49------
0.160.180.20.210.240.270.30.40.460.470.520.72.022.232.171.982.122.222.052.12.332.462.652.532.963.464.144.554.654.995.186.778.33000000
0.040.060.060.070.080.10.10.140.170.170.20.280.740.90.910.670.710.80.850.91.091.221.360.940.770.41.542.021.721.872.022.682.793.313.543.793.974.224.46
1.682.051.891.861.962.101.731.651.751.771.731.731.641.811.711.221.171.211.211.261.401.551.751.070.640.291.051.321.031.041.071.251.171.271.291.311.251.261.28
-0.03-0.02-0.01-0.02-0.210.010.040.050.050.070.10.120.350.440.470.270.470.470.250.50.640.710.720.430.27-0.141.430.361.660.86-3.411.541.72.412.62.853.13.393.65
--20.69-73.91216.67994.74-104.81250.0037.14-4.1745.6547.7625.25178.2327.836.12-43.3876.600.21-46.48100.4026.6410.991.70-39.64-36.87-150.36-1,134.78-74.51355.49-48.43-498.60-145.1610.3342.117.719.548.929.297.55
---------------------------------------
---------------------------------------
118118118118118147183201203207208251449464471431415376325303287278257235235218226222220212204.78208.47211.21000000
---------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Amerisourcebergen Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Amerisourcebergen is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
                                                           
0.030.030.030.070.060.050.060.120.30.660.80.871.321.331.110.881.011.661.831.071.231.812.172.742.442.493.374.62.923.39
0.250.270.320.390.530.510.610.622.142.222.32.262.643.433.423.483.923.833.793.796.056.318.229.1810.311.3113.5315.1919.4419.98
000000000000000000000000000488.43221.88172.57
0.350.350.410.651.020.951.241.575.065.445.735.1444.424.14.214.975.215.445.476.988.599.7610.7211.4611.9211.0612.5915.3715.56
22189144755162629272832317100555331273512985189210103169163189.3853.6487.87
0.630.650.771.121.631.561.922.327.518.358.868.37.999.218.948.679.9510.7511.3811.0614.3916.820.3322.8524.325.928.1333.0638.839.59
0.040.040.050.050.070.070.060.070.290.280.350.470.520.510.490.550.620.710.670.740.80.91.191.531.81.891.771.933.233.08
000000000000000000000000000000
000000000000000000000000000000
000000000000000.330.340.320.30.280.580.560.531.992.972.832.952.31.895.264.33
0.180000000.042.132.212.392.452.432.592.412.542.542.542.522.942.952.954.145.996.046.666.716.719.038.5
0.020.020.020.020.050.10.080.030.360.380.440.450.450.480.140.120.140.130.130.120.220.350.30.30.340.270.270.71.021.05
0.240.060.070.070.120.170.140.142.782.863.183.363.393.573.373.553.623.693.614.384.534.737.6310.7911.0111.7811.0411.2218.5416.97
0.870.710.841.191.751.732.062.4610.2911.2112.0411.6511.3812.7812.3112.2213.5714.4314.9815.4418.9221.5327.9633.6435.3237.6739.1744.2757.3456.56
                                                           
0000011111112225555333333332.882.912.93
0.010.010.170.230.230.260.270.282.712.863.133.153.313.473.583.693.743.94.082.252.362.753.744.334.524.724.855.085.475.66
-0.1-0.31-0.3-0.26-0.21-0.16-0.100.130.460.891.351.62.052.292.482.923.474.061.271.511.571.162.32.43.724.240.521.672.98
000000000-6-14-14-25-15-5-16-46-43-51-33-35-52-136-114-96-79-112-108.83-445.44-1,830.97
000000000000000000000000000000
-0.09-0.3-0.13-0.030.020.090.170.292.843.324.014.484.95.515.876.166.627.338.093.493.844.274.776.536.828.368.985.496.696.81
0.380.450.460.721.040.951.181.584.995.375.394.955.296.56.977.338.528.839.199.4913.3415.5920.8923.9325.426.8428.3931.7138.0140.19
0.030.030.030.030.040.050.050.050.360.430.440.420.340.40.330.270.320.370.410.570.530.560.690.741.40.881.061.652.862.21
00.040.040.040.050.090.10.120.180.240.370.460.420.550.570.570.650.70.881.211.10000000.190
000000000000000000000000000000
0000000000.060.060.280000000.3900000.610.010.150.140.50.31.07
0.410.520.530.791.131.091.331.755.536.16.266.16.057.467.868.179.489.9110.8711.2714.8717.2521.5825.2826.8227.8729.5833.8541.3643.48
0.550.490.440.430.590.540.560.411.871.761.721.160.951.091.231.191.181.340.971.41.423.743.853.784.514.353.626.384.63
00000000000000000000001.942.222.491.831.860.691.691.62
00.010.010.010.010.010.010.010.050.040.060.050.10.090.120.150.20.230.270.330.330.330.090.160.160.410.386.967.336.76
0.550.490.450.440.60.550.570.431.921.81.781.211.051.181.351.341.381.571.241.721.732.335.776.236.446.756.611.2615.3913.01
0.961.010.981.221.731.641.892.187.457.98.047.317.18.649.219.5110.8611.4812.1212.9916.619.5827.3531.5133.2534.6236.1845.1156.7556.49
0.870.710.851.191.751.732.072.4710.2911.2112.0411.81214.1515.0815.6717.4718.8120.2116.4820.4423.8532.1138.0340.0742.9845.1550.6163.4563.3
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Amerisourcebergen provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Amerisourcebergen's financial health and stability.

Assets

Amerisourcebergen's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Amerisourcebergen must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Amerisourcebergen after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Amerisourcebergen's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-0.01-0.02-0.210.010.040.050.050.070.10.120.340.440.470.260.470.470.250.50.640.710.720.430.27-0.141.430.361.620.85-3.41.541.67
16151410111419191724668087909297959489107140170196256392432510497408514709
00-5-15-519112524451274817891262848419461253820-130319-79528-1,544334196
-0.040.060.05-0.09-0.04-0.080.02-0.110.06-0.260-0.360.210.980.120.550.030.030.190.110.41-0.140.092.231.030.47-0.20.376.270.37-0.14
0.020.040.230.040.020.010.020.020.010.040.080.060.020.170.040.080.290.10.140.08-00.330.911.620.53-0.020.350.650.5500.36
523946433639513940501371341119462656856637484686291123125162167150170219
-1032620171726141111182001321072532621922572143023131972991710510411713993244
-0.020.10.08-0.040.04-0.010.1200.22-0.050.540.350.831.530.811.210.740.781.111.171.310.791.463.923.181.51.412.342.212.662.7
-8-7-8-13-15-16-12-15-16-23-64-90-189-203-111-111-137-145-176-156-133-202-264-231-464-466-336-310-369-438-496
-7-6-8-16-44-145-38-16-21117-202-201-242-501-42-674163-148-184-212-947117-384-2,931-3,169-498-1,111-375-379-6,141-368
010-2-28-128-26-1-4140-138-111-52-29869-563300-2-7-56-814319-119-2,699-2,704-31-774-65-10-5,703127
0000000000000000000000000000000
0.01-0.07-0.08-0.07-0.010.15-0.10.02-0.150.11-0.06-0.04-0.37-0.290.130.1-0.02-0.010.1800.0500.571.50.71-0.750.64-0.13-0.032.22-0.92
00014349368113010141-130-613-581-1,341-596-428-337-685-1,047-328-626-1,665168-227-500-597-194116-389
0.01-0.08-0.080.060.040.15-0.090.02-0.130.110.03-0.02-0.51-0.93-0.47-1.15-0.66-0.5-0.28-0.79-1.12-0.74-0.5-0.630.57-1.31-0.24-1.09-0.61.95-1.75
-3-130-100-3-100-321-7-1-18-2122-1-4-251510-216-228-209-28-16-44-16-33-13-48
0000000000-10-11-11-10-20-37-48-62-90-117-132-195-214-253-288-320-333-339-343-366-391
-0.020.01-00.010.03-0.01-0.010.010.060.180.370.140.070.10.29-0.620.240.130.650.17-0.760.160.580.360.57-0.310.060.881.22-1.530.52
-26.391.675.5-49.324.3-26.9108.8-12.8200-69.3471.7264.2635.81,323.2695.41,096.6599.8638932.11,011.81,172.1585.61,200.23,690.62,713.91,037.71,0752,033.81,837.362,226.622,206.16
0000000000000000000000000000000

Amerisourcebergen stock margins

The Amerisourcebergen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Amerisourcebergen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Amerisourcebergen.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Amerisourcebergen's sales revenue. A higher gross margin percentage indicates that the Amerisourcebergen retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Amerisourcebergen's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Amerisourcebergen's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Amerisourcebergen's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Amerisourcebergen. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Amerisourcebergen's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Amerisourcebergen Margin History

Amerisourcebergen Gross marginAmerisourcebergen Profit marginAmerisourcebergen EBIT marginAmerisourcebergen Profit margin
2028e3.49 %1.28 %1.04 %
2027e3.49 %1.26 %1.02 %
2026e3.49 %1.25 %0.97 %
2025e3.49 %1.31 %0.98 %
2024e3.49 %1.29 %0.95 %
2023e3.49 %1.27 %0.93 %
20223.49 %1.17 %0.71 %
20213.17 %1.25 %0.72 %
20202.73 %1.07 %-1.8 %
20192.78 %1.04 %0.48 %
20182.77 %1.03 %0.99 %
20172.97 %1.32 %0.24 %
20162.82 %1.05 %0.97 %
20152.55 %0.29 %-0.1 %
20142.47 %0.64 %0.23 %
20132.88 %1.07 %0.49 %
20123.39 %1.75 %0.92 %
20113.13 %1.55 %0.9 %
20102.99 %1.4 %0.82 %
20092.93 %1.26 %0.7 %
20082.92 %1.21 %0.36 %
20073.38 %1.21 %0.71 %
20063.49 %1.17 %0.77 %
20053.63 %1.22 %0.49 %
20044.08 %1.71 %0.88 %
20034.49 %1.81 %0.89 %

Amerisourcebergen Stock Sales Revenue, EBIT, Earnings per Share

The Amerisourcebergen earnings per share therefore indicates how much revenue Amerisourcebergen has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Amerisourcebergen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Amerisourcebergen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Amerisourcebergen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Amerisourcebergen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Amerisourcebergen Revenue, EBIT and net profit per share

DateAmerisourcebergen Sales per ShareAmerisourcebergen EBIT per shareAmerisourcebergen Earnings per Share
2028e1,742.23 undefined0 undefined18.15 undefined
2027e1,659.67 undefined0 undefined16.88 undefined
2026e1,586.03 undefined0 undefined15.44 undefined
2025e1,440.86 undefined0 undefined14.18 undefined
2024e1,369.29 undefined0 undefined12.94 undefined
2023e1,298.21 undefined0 undefined12.01 undefined
20221,129.62 undefined13.22 undefined8.04 undefined
20211,026.5 undefined12.83 undefined7.39 undefined
2020927.29 undefined9.89 undefined-16.65 undefined
2019847.12 undefined8.81 undefined4.03 undefined
2018763.36 undefined7.83 undefined7.54 undefined
2017689.84 undefined9.09 undefined1.64 undefined
2016649.78 undefined6.83 undefined6.32 undefined
2015623.68 undefined1.81 undefined-0.63 undefined
2014508.8 undefined3.26 undefined1.17 undefined
2013374.29 undefined4.02 undefined1.85 undefined
2012303.82 undefined5.3 undefined2.8 undefined
2011283.08 undefined4.4 undefined2.54 undefined
2010271 undefined3.8 undefined2.22 undefined
2009236.83 undefined2.97 undefined1.66 undefined
2008215.97 undefined2.6 undefined0.77 undefined
2007174.66 undefined2.11 undefined1.25 undefined
2006146.53 undefined1.72 undefined1.13 undefined
2005126.63 undefined1.54 undefined0.61 undefined
2004112.78 undefined1.93 undefined0.99 undefined
2003106.86 undefined1.93 undefined0.95 undefined

Amerisourcebergen business model

AmerisourceBergen Corp is a global healthcare company that offers a variety of products and services to its customers. It was founded in 2001 through the merger of AmeriSource Health Corp and Bergen Brunswig Corp. The company's business model is based on providing products, services, and technologies for various areas of the healthcare industry, including pharmacy, biotechnology, healthcare services, and retail. AmerisourceBergen Corp has three main business segments: Pharmaceutical Distribution Services, Provider Services, and Pharmaceutical Manufacturer Services. The pharmaceutical distribution service provides fast and reliable delivery of drugs and medical devices to pharmacies, wholesalers, and healthcare facilities. The provider service helps patients get the right medications and offers clinical services to medical facilities. The pharmaceutical manufacturer distribution provides support to its customers in the manufacturing, quality control, and marketing of drugs. The company also offers technology solutions that enable more patient-centered care and improve communication between doctors and patients. AmerisourceBergen Corp has extensive experience and expertise in the industry. It operates a wide network of branches and logistics centers worldwide to ensure its customers always receive the products and services they need. The company offers a wide range of pharmaceutical products, specialized disease drugs, biosimilars, vaccines, and medical devices. It also provides services such as consulting on drug manufacturing and approval, as well as logistics, financial, marketing, and information technology services for its customers. Over the years, AmerisourceBergen Corp has received numerous awards for its outstanding performance in the healthcare industry. The company is known for its commitment to patient-centered care and its innovative solutions to healthcare supply chain issues. With a strong reputation for quality and customer satisfaction, AmerisourceBergen Corp remains one of the leading companies in the healthcare industry. Amerisourcebergen is one of the most popular companies on Eulerpool.com.

Amerisourcebergen SWOT Analysis

Strengths

1. Established market presence: AmerisourceBergen Corp has a strong foothold in the pharmaceutical distribution industry, benefiting from its long-standing history and extensive network.

2. Diverse product portfolio: The company offers a comprehensive range of pharmaceutical products, including generic drugs and specialty medications, enabling it to cater to diverse customer needs.

3. Strong partnerships: AmerisourceBergen has formed strategic alliances with key industry players, such as pharmaceutical manufacturers, pharmacies, and healthcare providers, enhancing its competitive advantage.

Weaknesses

1. Dependence on key customers: AmerisourceBergen relies heavily on a few major customers for a significant portion of its revenue. This dependency exposes the company to potential risks if these customers reduce their orders or seek alternative distribution channels.

2. Vulnerability to industry regulations: As a healthcare-related company, AmerisourceBergen is subject to stringent regulations and policies that can impact its operations and profitability. Changes in legislation or government policies pose a risk to the company's growth.

3. Potential supply chain disruptions: Any disruption in the supply chain, such as delays in product delivery or shortages, could negatively impact AmerisourceBergen's reputation and customer relationships.

Opportunities

1. Growing demand for specialty drugs: The increasing prevalence of chronic diseases and advancements in pharmaceutical research present an opportunity for AmerisourceBergen to expand its specialty drug offerings and capture a larger market share.

2. Digitalization and technology advancements: The adoption of technology in healthcare, such as e-commerce platforms and data analytics, offers opportunities for AmerisourceBergen to improve operational efficiencies and enhance customer experience.

3. International expansion: Expanding into emerging markets or through partnerships with global pharmaceutical companies can provide AmerisourceBergen with access to new customer bases and revenue streams.

Threats

1. Pricing pressures: The pharmaceutical distribution industry is highly competitive, leading to potential pricing pressures from customers and suppliers. Fee compression and margin erosion pose risks to AmerisourceBergen's profitability.

2. Counterfeit and illegal drugs: The presence of counterfeit or illegal drugs in the market poses a threat to AmerisourceBergen's reputation and could result in legal and regulatory issues.

3. Industry consolidation: Mergers and acquisitions within the pharmaceutical distribution industry can create larger competitors and disrupt AmerisourceBergen's market position and growth strategies.

Amerisourcebergen Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Amerisourcebergen historical P/E ratio, EBIT, and P/S ratio.

Amerisourcebergen shares outstanding

The number of shares was Amerisourcebergen in 2023 — This indicates how many shares 211.21 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Amerisourcebergen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Amerisourcebergen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Amerisourcebergen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Amerisourcebergen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Amerisourcebergen Stock splits

In Amerisourcebergen's history, there have been no stock splits.

Amerisourcebergen dividend history and estimates

In 2023, Amerisourcebergen paid a dividend amounting to 1.94 USD. Dividend means that Amerisourcebergen distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Amerisourcebergen provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Amerisourcebergen’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Amerisourcebergen's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Amerisourcebergen Dividend History

DateAmerisourcebergen Dividend
20221.87 undefined
20211.78 undefined
20201.7 undefined
20191.6 undefined
20181.54 undefined
20171.48 undefined
20161.39 undefined
20151.21 undefined
20140.99 undefined
20131.31 undefined
20120.6 undefined
20110.46 undefined
20100.34 undefined
20090.24 undefined
20080.16 undefined
20070.11 undefined
20060.06 undefined
20050.03 undefined
20040.03 undefined
20030.03 undefined

Amerisourcebergen dividend payout ratio

In 2023, Amerisourcebergen had a payout ratio of 29%. The payout ratio indicates the percentage of the company's profits that Amerisourcebergen distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Amerisourcebergen represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Amerisourcebergen could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Amerisourcebergen's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Amerisourcebergen Payout Ratio History

DateAmerisourcebergen Payout ratio
2028e26.22 %
2027e26.02 %
2026e26.76 %
2025e25.87 %
2024e25.43 %
2023e29 %
202223.19 %
202124.1 %
2020-10.21 %
201939.7 %
201820.45 %
201789.94 %
201621.91 %
2015-192.06 %
201485.78 %
201371.2 %
201221.51 %
201118.11 %
201015.38 %
200914.46 %
200821.1 %
20078.93 %
20065.58 %
20055.12 %
20042.53 %
20032.63 %
Unfortunately, there are currently no price targets and forecasts available for Amerisourcebergen.

Amerisourcebergen list of shareholders

%
Name
Stocks
Change
Date
4.52958 % BlackRock Institutional Trust Company, N.A.9,097,851667,03012/31/2022
3.67894 % State Street Global Advisors (US)7,389,304398,83812/31/2022
2.81565 % JP Morgan Asset Management5,655,338-828,76112/31/2022
2.59266 % Fidelity Management & Research Company LLC5,207,463-123,65612/31/2022
2.58969 % Boston Partners5,201,488159,84912/31/2022
16.75803 % Walgreens Boots Alliance Inc33,659,180-5,961,53412/12/2022
10.09337 % The Vanguard Group, Inc.20,272,9281,123,47612/31/2022
1.97222 % T. Rowe Price Associates, Inc.3,961,2823,960,27712/31/2022
1.62135 % Geode Capital Management, L.L.C.3,256,549169,98012/31/2022
1.43864 % BlackRock Financial Management, Inc.2,889,56864,03712/31/2022
1
2
3
4
5
...
10

Amerisourcebergen Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Cigna Corporation Stock
Cigna Corporation
SupplierCustomer0,930,440,700,860,770,70
United Parcel Service, Inc. Stock
United Parcel Service, Inc.
SupplierCustomer0,890,61-0,31-0,46-0,110,60
Amphastar Pharmaceuticals Stock
Amphastar Pharmaceuticals
SupplierCustomer0,86-0,330,800,950,960,83
Bristol-Myers Squibb Company Stock
Bristol-Myers Squibb Company
SupplierCustomer0,770,420,780,970,750,74
Exelixis Stock
Exelixis
SupplierCustomer0,660,190,470,850,48-0,25
OMNIQ Corp Stock
OMNIQ Corp
SupplierCustomer0,64-0,110,44-0,30-0,76-
Alexion Pharmaceuticals, Inc. Stock
Alexion Pharmaceuticals, Inc.
SupplierCustomer0,560,390,560,870,84-
Eli Lilly Stock
Eli Lilly
SupplierCustomer0,56-0,050,750,750,770,87
Endo International plc Stock
Endo International plc
SupplierCustomer0,530,140,14-0,80-0,66-0,47
Omeros Stock
Omeros
SupplierCustomer0,51-0,15-0,26-0,63-0,70-0,61
1
2
3
4
5
...
8

Most common questions regarding Amerisourcebergen

What values and corporate philosophy does Amerisourcebergen represent?

AmerisourceBergen Corp represents a strong commitment to integrity, innovation, and collaboration. The company values client relationships and aims to provide superior service by fulfilling the healthcare needs of their customers. With a mission to improve patient access to pharmaceuticals and medical products, AmerisourceBergen Corp operates under the corporate philosophy that emphasizes reliable distribution networks, cutting-edge technology solutions, and industry expertise. By leveraging their extensive network, they work towards delivering exceptional value to healthcare providers and pharmaceutical manufacturers. AmerisourceBergen Corp strives to foster a culture of trust, integrity, and transparency, ensuring sustainable growth and success in the healthcare industry.

In which countries and regions is Amerisourcebergen primarily present?

AmerisourceBergen Corp is primarily present in the United States, one of the largest pharmaceutical markets globally. With headquarters in Pennsylvania, the company operates in various regions across the US, including key cities like California, New York, Texas, and Florida. AmerisourceBergen provides pharmaceutical distribution and related services to a wide range of healthcare providers, including hospitals, pharmacies, and physician practices. With a strong presence across the American healthcare landscape, AmerisourceBergen Corp plays a vital role in ensuring the efficient and reliable distribution of pharmaceutical products throughout the United States.

What significant milestones has the company Amerisourcebergen achieved?

AmerisourceBergen Corp, a leading global healthcare solutions company, has achieved several significant milestones. The company has consistently expanded its market reach through strategic acquisitions and partnerships, solidifying its position as a major player in the pharmaceutical distribution industry. AmerisourceBergen Corp has also demonstrated its commitment to innovation by adopting advanced technologies and enhancing its digital capabilities. Furthermore, the company's strong financial performance, consistent revenue growth, and successful execution of its business strategies have contributed to its continuous success and recognition as a Fortune 11 company. AmerisourceBergen Corp's dedication to serving the healthcare needs of patients and providing exceptional value to its customers have allowed it to become a trusted partner in the industry.

What is the history and background of the company Amerisourcebergen?

AmerisourceBergen Corp, founded in 2001, is a global healthcare solutions company based in the United States. It specializes in pharmaceutical sourcing and distribution services, serving both pharmaceutical manufacturers and healthcare providers. With its extensive network of distribution centers, AmerisourceBergen offers a wide range of products and services to support patient care and deliver vital medications. The company has a rich history of growth and innovation, expanding its operations globally and establishing itself as a leader in the healthcare industry. AmerisourceBergen continues to evolve and adapt to the changing needs of the healthcare landscape, striving to improve patient outcomes and advance the delivery of healthcare services.

Who are the main competitors of Amerisourcebergen in the market?

The main competitors of AmerisourceBergen Corp in the market include McKesson Corporation and Cardinal Health Inc. These companies are key players in the pharmaceutical distribution industry, providing similar services and products. AmerisourceBergen Corp competes with these rivals in terms of market share, customer relationships, and supply chain management. These competitors also operate on a global scale, catering to the needs of healthcare providers and pharmaceutical manufacturers. Overall, AmerisourceBergen faces strong competition from McKesson Corporation and Cardinal Health Inc in its efforts to maintain its position as a leading player in the pharmaceutical distribution market.

In which industries is Amerisourcebergen primarily active?

AmerisourceBergen Corp primarily operates in the pharmaceutical distribution industry.

What is the business model of Amerisourcebergen?

AmerisourceBergen Corp is a leading global pharmaceutical sourcing and distribution company. Its business model primarily focuses on providing pharmaceutical products and services to various healthcare providers, including hospitals, pharmacies, and physicians. As a key player in the healthcare supply chain, AmerisourceBergen operates through three main segments: Pharmaceutical Distribution Services, Global Commercialization Services, and Animal Health. Through these segments, the company offers a comprehensive range of services, including sourcing, packaging, logistics, and technology solutions. AmerisourceBergen Corp collaborates with pharmaceutical manufacturers to ensure the efficient delivery of vital medications and healthcare products to patients worldwide.

What is the P/E ratio of Amerisourcebergen 2024?

The Amerisourcebergen P/E ratio is 15.06.

What is the P/S ratio of Amerisourcebergen 2024?

The Amerisourcebergen P/S ratio is 0.14.

What is the AlleAktien quality score of Amerisourcebergen?

The AlleAktien quality score for Amerisourcebergen is 7/10.

What is the revenue of Amerisourcebergen 2024?

The expected Amerisourcebergen revenue is 275.03 B USD.

How high is the profit of Amerisourcebergen 2024?

The expected Amerisourcebergen profit is 2.6 B USD.

What is the business model of Amerisourcebergen

AmerisourceBergen Corp is an international company based in the USA that specializes in providing innovative solutions in the healthcare industry. The company offers a wide range of products and services that enable healthcare facilities to operate more efficiently and improve patient care. The business model of AmerisourceBergen Corp is based on three main business areas: 1. Pharmaceutical Distribution: The company is one of the largest pharmaceutical distributors in North America and offers a wide range of products and services to meet the demand for pharmaceuticals and medications. This includes specialty pharmaceuticals, biosimilars, and generics. 2. Outsourcing Services: AmerisourceBergen offers a variety of outsourcing services, including medication manufacturing, supply chain support, and consultation and training for healthcare professionals. 3. Value Assessment: Lastly, AmerisourceBergen provides value assessment services that enable customers to better understand and communicate the impact and benefits of their products. Together, these three business areas form the foundation of AmerisourceBergen's business model and enable the company to offer a variety of products and services to improve the quality of patient care and efficiency in the healthcare industry. One example of the products offered by AmerisourceBergen is oncology therapies. The company is a major provider of cancer medications in North America. It also works closely with insurance companies and other partners to ensure that cancer patients have access to necessary treatments and services. This product is an example of how AmerisourceBergen combines its core business areas to meet the demand for innovative solutions in healthcare. SEO-optimized terms found in this text include "pharmaceutical distributors," "outsourcing services," "value assessment services," and "oncology therapies." These terms are used to clarify the topic of the text and increase traffic to the AmerisourceBergen website by being found by search engines. By using such key terms, the text also strengthens the online visibility of AmerisourceBergen and contributes to improving the company's online marketing strategy.

What is the Amerisourcebergen dividend?

Amerisourcebergen pays a dividend of 1.87 USD distributed over 4 payouts per year.

How often does Amerisourcebergen pay dividends?

Amerisourcebergen pays out a dividend 4 times a year.

What is the Amerisourcebergen ISIN?

The ISIN of Amerisourcebergen is US03073E1055.

What is the Amerisourcebergen WKN?

The WKN of Amerisourcebergen is 766149.

What is the Amerisourcebergen ticker?

The ticker of Amerisourcebergen is ABC.

How much dividend does Amerisourcebergen pay?

Over the past 12 months, Amerisourcebergen paid a dividend of 1.87 USD . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Amerisourcebergen is expected to pay a dividend of 1.94 USD.

What is the dividend yield of Amerisourcebergen?

The current dividend yield of Amerisourcebergen is 1.01 %.

When does Amerisourcebergen pay dividends?

Amerisourcebergen pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Amerisourcebergen?

Amerisourcebergen paid dividends every year for the past 26 years.

What is the dividend of Amerisourcebergen?

For the upcoming 12 months, dividends amounting to 1.94 USD are expected. This corresponds to a dividend yield of 1.05 %.

In which sector is Amerisourcebergen located?

Amerisourcebergen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amerisourcebergen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amerisourcebergen from 8/28/2023 amounting to 0.485 USD, you needed to have the stock in your portfolio before the ex-date on 8/10/2023.

When did Amerisourcebergen pay the last dividend?

The last dividend was paid out on 8/28/2023.

What was the dividend of Amerisourcebergen in the year 2023?

In the year 2023, Amerisourcebergen distributed 1.865 USD as dividends.

In which currency does Amerisourcebergen pay out the dividend?

The dividends of Amerisourcebergen are distributed in USD.

All fundamentals about Amerisourcebergen

Our stock analysis for Amerisourcebergen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amerisourcebergen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.